Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Kotani

Showing results (21-30 of 108) with videos related to

Pageof 11
Sort By:
Lupus|April 20, 2022
Low pre-pregnant body mass index is a risk factor for the decrease of postpartum bone mineral density in systemic lupus erythematosus patients received glucocorticoid therapyTakaaki Ishida, Hiramatsu Yuri, Eri Nakamura, et al.
Modern Rheumatology|April 4, 2015
Therapeutic drug monitoring of cyclosporine microemulsion in patients with corticosteroid-resistant systemic lupus erythematosusYumiko Wada, Takuya Kotani, Tohru Takeuchi, et al.
International Journal of Molecular Sciences|November 11, 2022
Association between Serum Biomarkers and Peripheral Neuropathy in Microscopic PolyangiitisYuichi Masuda, Shogo Matsuda, Takuya Kotani, et al.
International Journal of Molecular Sciences|October 29, 2025
Evaluating the Dose-Dependent Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Preclinical Model of Interstitial Lung DiseaseTakuya Kotani, Takashi Saito, Ryota Masutani, et al.
Modern Rheumatology|May 12, 2017
Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patientsYouhei Fujiki, Takuya Kotani, Kentaro Isoda, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 6, 2005
[A case of interstitial pneumonia associated with dermatomyositis effectively treated with cyclosporin-A and cyclophosphamide pulse]Takuya Kotani, Shigeki Makino, Yoshiko Kawasaki, et al.
Scientific Reports|November 25, 2021
Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathyAkihiro Tsukahara, Takafumi Hosokawa, Daisuke Nishioka, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 3, 2007
[A patient with interstitial pneumonia associated with dermatomyositis who relapsed after reducing cyclosporin-A treatment]Takuya Kotani, Shigeki Makino, Takeshi Shoda, et al.
Journal of Neurology|April 15, 2019
Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitisHiroki Tani, Koji Nagai, Takafumi Hosokawa, et al.
The Journal of Rheumatology|December 19, 2007
Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositisTakuya Kotani, Shigeki Makino, Tohru Takeuchi, et al.
Pageof 11

Showing results (21-30 of 108) with videos related to

Sort By:
Pageof 11
Lupus|April 20, 2022
Low pre-pregnant body mass index is a risk factor for the decrease of postpartum bone mineral density in systemic lupus erythematosus patients received glucocorticoid therapyTakaaki Ishida, Hiramatsu Yuri, Eri Nakamura, et al.
Modern Rheumatology|April 4, 2015
Therapeutic drug monitoring of cyclosporine microemulsion in patients with corticosteroid-resistant systemic lupus erythematosusYumiko Wada, Takuya Kotani, Tohru Takeuchi, et al.
International Journal of Molecular Sciences|November 11, 2022
Association between Serum Biomarkers and Peripheral Neuropathy in Microscopic PolyangiitisYuichi Masuda, Shogo Matsuda, Takuya Kotani, et al.
International Journal of Molecular Sciences|October 29, 2025
Evaluating the Dose-Dependent Effects of Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Preclinical Model of Interstitial Lung DiseaseTakuya Kotani, Takashi Saito, Ryota Masutani, et al.
Modern Rheumatology|May 12, 2017
Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patientsYouhei Fujiki, Takuya Kotani, Kentaro Isoda, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 6, 2005
[A case of interstitial pneumonia associated with dermatomyositis effectively treated with cyclosporin-A and cyclophosphamide pulse]Takuya Kotani, Shigeki Makino, Yoshiko Kawasaki, et al.
Scientific Reports|November 25, 2021
Neuron-specific enolase level is a useful biomarker for distinguishing amyotrophic lateral sclerosis from cervical spondylotic myelopathyAkihiro Tsukahara, Takafumi Hosokawa, Daisuke Nishioka, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 3, 2007
[A patient with interstitial pneumonia associated with dermatomyositis who relapsed after reducing cyclosporin-A treatment]Takuya Kotani, Shigeki Makino, Takeshi Shoda, et al.
Journal of Neurology|April 15, 2019
Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitisHiroki Tani, Koji Nagai, Takafumi Hosokawa, et al.
The Journal of Rheumatology|December 19, 2007
Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositisTakuya Kotani, Shigeki Makino, Tohru Takeuchi, et al.
Pageof 11